Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251810012 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von María Inmaculada Domínguez-Mozo und 19 weiteren Autor:innen. Beteiligte Einrichtung: Research Group in Environmental Factors of Neurodegenerative Diseases, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC),…. Hauptthemen laut MEDLINE: Neurofilament Proteins, MicroRNAs, Multiple Sclerosis, Biomarkers. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Fundación LAIR, Fundación Mutua Madrileña.
Abstract (Originalsprache)
microRNAs (miRNAs) are promising biomarkers for many diseases, including multiple sclerosis (MS). The neurofilament light chain (NfL) is a biomarker that can detect axonal damage in different neurological diseases. The objective of this study was to evaluate the association of the expression profile of pre-selected miRNAs and NfL levels with clinical and radiological variables in MS patients. We conducted a 1-year longitudinal prospective study in MS patients with different clinical forms. We measured clinical disability using the expanded disability status scale (EDSS), the magnetic resonance imaging (MRI) volumetry baseline, and cognitive functioning using the processing speed test (PST) at baseline and 1 year later. Selected serum miRNAs and serum NfL (sNfL) levels were quantified. Seventy-three patients were recruited. MiR-126.3p correlated with EDSS and cognitive status at baseline and miR-126.3p and miR-9p correlated with cognitive deterioration at 1 year. Correlations with regional brain volumes were observed between miR-126.3p and the cortical gray matter, cerebellum, putamen, and pallidum; miR-146a.5p with the cerebellum and pallidum; miR-29b.3p with white matter and the pallidum; miR-138.5p with the pallidum; and miR-9.5p with the thalamus. sNfL was correlated with miR-9.5p. miR-146a.5p was also associated with the MS phenotype. These data justify future studies to further explore the utility of miRNAs (mirR-126.3p, miR-146.5p, and miR.9-5p) and sNfL levels as biomarkers of MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Group in Environmental Factors of Neurodegenerative Diseases, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Red de Enfermedades Inflamatorias (REI), 28040 Madrid, Spain.
- Department of Neurology, Hospital Universitario de Torrejón, 28850 Madrid, Spain.
- School of Medicine, Universidad Francisco de Vitoria, 28223 Madrid, Spain.
- Department of Neurology, Hospital Universitario QuironSalud Madrid, Pozuelo de Alarcón, 28223 Madrid, Spain.
- Department of Neurology, Hospital Universitario Ramón y Cajal, Red de Enfermedades Inflamatorias (REI), Instituto Ramón y Cajal de Investigación Sanitaria, Universidad de Alcalá, 28034 Madrid, Spain.
- Department of Neurology, Hospital Universitario de Getafe, 28905 Madrid, Spain.
ORCID-Profile: Ignacio Casanova, Lucienne Costa-Frossard, Susana Sainz-de-la-Maza, Yolanda Aladro-Benito, David De-la-Cuesta, Daniel Lourido, Angel Torrado-Carvajal, Luisa Maria Villar, Roberto Alvarez-Lafuente
Förderung
- Ministerio de Ciencia, Innovación y Universidades
- Fundación LAIR
- Fundación Mutua Madrileña
- Ministry of Science and Innovation (Knowledge generation projects) European Regional Development Fund (ERDF)
- LAIR Foundation
- Mutua Madrileña Foundation
Zitieren
APA
Domínguez-Mozo, M. I., Casanova, I., Monreal, E., Costa-Frossard, L., Sainz-de-la-Maza, S., Sainz-Amo, R., Aladro-Benito, Y., Lopez-Ruiz, P., De-Torres, L., Abellán, S., Garcia-Martinez, M. A., De-la-Cuesta, D., Lourido, D., Torrado-Carvajal, A., Gomez-Barbosa, C., Linares-Villavicencio, C., Villar, L. M., López-De-Silanes, C., Arroyo, R., & Alvarez-Lafuente, R. (2024). Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810012
Vancouver
Domínguez-Mozo MI, Casanova I, Monreal E, Costa-Frossard L, Sainz-de-la-Maza S, Sainz-Amo R, et al. Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810012
BibTeX
@article{DomnguezMozo2024,
author = {Domínguez-Mozo, María Inmaculada and Casanova, Ignacio and Monreal, Enric and Costa-Frossard, Lucienne and Sainz-de-la-Maza, Susana and Sainz-Amo, Raquel and Aladro-Benito, Yolanda and Lopez-Ruiz, Pedro and De-Torres, Laura and Abellán, Sara and Garcia-Martinez, Maria Angel and De-la-Cuesta, David and Lourido, Daniel and Torrado-Carvajal, Angel and Gomez-Barbosa, Carol and Linares-Villavicencio, Carla and Villar, Luisa Maria and López-De-Silanes, Carlos and Arroyo, Rafael and Alvarez-Lafuente, Roberto},
title = {Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251810012}
}
EUVIMED